Cidara Therapeutics Inc (NASDAQ:CDTX)
| 1.35 Delayed Data As of May 26 |  +0.07 / +5.47%Today’s Change | 0.40 Today|||52-Week Range 2.10 | +78.50% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 137.0K | 111.0K | 86.0K | 84.0K | ||
| Operating Expenses | Gross Income | -137.0K | -111.0K | -86.0K | -84.0K | |
| General Expenses | 14.6M | 16.5M | 16.3M | 14.2M | ||
| Research And Development | 11.3M | 13.0M | 12.7M | 10.7M | ||
| Total Operating Expenses | 14.7M | 16.6M | 16.4M | 14.3M | ||
| Non-Operating Expenses | Operating Income | -14.7M | -16.6M | -16.4M | -14.3M | |
| Extraordinary Credit | 888.0K | 4.1M | 0.00 | 681.0K | ||
| Extraordinary Charge | 0.00 | 0.00 | -270.0K | 0.00 | ||
| Other Expenses | 218.0K | -1.0K | 113.0K | 40.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -13.6M | -12.3M | -16.6M | -13.5M | |
| Net Income | -13.6M | -12.3M | -16.6M | -13.5M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 27.7M | 27.8M | 27.7M | 27.8M | |
| Shares To Calculate EPS Diluted | 27.7M | 27.8M | 27.7M | 27.8M | ||
| Earnings Per Share | EPS | -$0.49 | -$0.44 | -$0.60 | -$0.49 | |
| EPS Diluted | -$0.49 | -$0.44 | -$0.60 | -$0.49 | ||
